Adaptimmune Therapeutics plc (MUN:473A)
Germany flag Germany · Delayed Price · Currency is EUR
0.0160
0.00 (0.00%)
Last updated: Jun 2, 2026, 8:00 AM CET

Adaptimmune Therapeutics Statistics

Total Valuation

MUN:473A has a market cap or net worth of EUR 6.37 million. The enterprise value is -3.82 million.

Market Cap6.37M
Enterprise Value -3.82M

Important Dates

The next estimated earnings date is Thursday, August 13, 2026.

Earnings Date Aug 13, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +11.11%
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.65%
Owned by Institutions (%) 0.00%
Float 263.34M

Valuation Ratios

The trailing PE ratio is 0.30.

PE Ratio 0.30
Forward PE n/a
PS Ratio 1.26
PB Ratio 0.23
P/TBV Ratio 0.23
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -0.18
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 0.04

Financial Position

The company has a current ratio of 2.04, with a Debt / Equity ratio of 0.44.

Current Ratio 2.04
Quick Ratio 1.64
Debt / Equity 0.44
Debt / EBITDA n/a
Debt / FCF -0.12
Interest Coverage -8.82

Financial Efficiency

Return on equity (ROE) is -356.05% and return on invested capital (ROIC) is -60.67%.

Return on Equity (ROE) -356.05%
Return on Assets (ROA) -25.91%
Return on Invested Capital (ROIC) -60.67%
Return on Capital Employed (ROCE) -155.93%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 9,971
Profits Per Employee 42,427
Employee Count506
Asset Turnover 0.04
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 0.01
200-Day Moving Average n/a
Relative Strength Index (RSI) 47.15
Average Volume (20 Days) 535

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, MUN:473A had revenue of EUR 5.05 million and earned 21.47 million in profits. Earnings per share was 0.08.

Revenue5.05M
Gross Profit 5.05M
Operating Income -54.61M
Pretax Income -66.44M
Net Income 21.47M
EBITDA -44.99M
EBIT -54.61M
Earnings Per Share (EPS) 0.08
Full Income Statement

Balance Sheet

The company has 22.10 million in cash and 11.99 million in debt, with a net cash position of 10.11 million.

Cash & Cash Equivalents 22.10M
Total Debt 11.99M
Net Cash 10.11M
Net Cash Per Share n/a
Equity (Book Value) 27.23M
Book Value Per Share 0.10
Working Capital 19.65M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -103.83 million and capital expenditures -330,460, giving a free cash flow of -104.16 million.

Operating Cash Flow -103.83M
Capital Expenditures -330,460
Depreciation & Amortization 9.73M
Net Borrowing -47.83M
Free Cash Flow -104.16M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -1,082.41% and 425.49%.

Gross Margin 100.00%
Operating Margin -1,082.41%
Pretax Margin -1,316.78%
Profit Margin 425.49%
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MUN:473A does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -11.11%
Shareholder Yield -11.11%
Earnings Yield 336.83%
FCF Yield -1,634.24%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2